Rebecca Taub's Net Worth
$130 Million
Who is Rebecca Taub?
Rebecca Taub has an estimated net worth of $130 Million. This is based on reported shares across multiple companies, which include MADRIGAL PHARMACEUTICALS, INC., BriaCell Therapeutics Corp., and VIA Pharmaceuticals, Inc..
SEC CIK
Rebecca Taub's CIK is 0001423898
Past Insider Trading and Trends
2024 was Rebecca Taub's most active year for acquiring shares with 7 total transactions. Rebecca Taub's most active month to acquire stocks was the month of June. 2024 was Rebecca Taub's most active year for disposing of shares, totalling 30 transactions. Rebecca Taub's most active month to dispose stocks was the month of March. 2024 saw Rebecca Taub paying a total of $723,529.80 for 96,854 shares, this is the most they've acquired in one year. In 2024 Rebecca Taub cashed out on 154,674 shares for a total of $19,057,946.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Snapshot price: $243.89
Pres., R&D, and CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$127.72 | -$632,969.41 | 459K |
Apr 8
| |||
Form 4
|
—
|
0
|
$126.68 | -$17,324,346.87 | 459K |
Scheduled
|
Apr 3 - Apr 5
| ||
Form 4
| +38.57% | 5.79K |
—
|
—
| 20.79K |
Jan 23
| |||
Form 4
| -9.34% | -1.55K |
$243.92 | -$377,100.32 | 15K |
Jan 16
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +12.63% | 73.53K |
$287.46 | $21,135,783.96 | 655.54K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4/A
| +7.58% | 30.63K |
—
|
—
| 434.76K |
Jul 22
| |||
Form 4
|
∞
| 1.16M |
—
|
—
| 1.16M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BriaCell Therapeutics Corp. (BCTX) Snapshot price: $0.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VIA Pharmaceuticals, Inc. No price found
SVP, Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 157.5K |
$0.30 | $9,750.00 | 157.5K |
Dec 5 - Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |